Genedrive Plc, formerly Epistem Holdings Plc, is a holding company engaged in molecular diagnostics business. The Company operates through segments, including Preclinical Research Services, Pharmacogenomics Services and Diagnostics. Its geographical segments include the United Kingdom, Europe, the United States of America and Asia. Its Preclinical Research Services segment provides pre-clinical testing services. Its Pharmacogenomic Services segment specializes in molecular measures of biological effect. Its Diagnostics segment is commercializing the Genedrive molecular testing platform. Its Preclinical Research Services activities relate to the testing of drugs for drug development companies. The Preclinical Research Services division has developed a range of models across therapeutic pathways, including oncology, gastrointestinal disease, skin care and wound healing. The Pharmacogenomics Service offers multi system transcriptional profiling and laser capture microscopy.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Biotechnology & Medical Research - NEC
- Sub-Industry: N/A
- Symbol: LON:GDR
- CUSIP: N/A
- Web: www.genedriveplc.com/
- Market Cap: £7.75 million
- Outstanding Shares: 18,245,000
- 52 Week Range: GBX 30 - GBX 82.50
Sales & Book Value:
- Trailing P/E Ratio:
- P/E Growth:
- Annual Revenue: £5.97 million
- Price / Sales: 1.30
- Book Value: GBX 0.39 per share
- Price / Book: 1.09
- EBIDTA: ($3,560,000.00)
- Net Margins: -93.79%
- Return on Equity: -99.47%
- Return on Assets: -38.99%
- Average Volume: 5,292 shs.
Frequently Asked Questions for Genedrive PLC (LON:GDR)
What is Genedrive PLC's stock symbol?
Genedrive PLC trades on the London Stock Exchange (LON) under the ticker symbol "GDR."
When will Genedrive PLC make its next earnings announcement?
Where is Genedrive PLC's stock going? Where will Genedrive PLC's stock price be in 2017?
1 brokerages have issued 1-year target prices for Genedrive PLC's shares. Their predictions range from GBX 200 to GBX 200. On average, they expect Genedrive PLC's stock price to reach GBX 200 in the next year. View Analyst Ratings for Genedrive PLC.
Who are some of Genedrive PLC's key competitors?
Some companies that are related to Genedrive PLC include Novogen Limited (NVGN), RXi Pharmaceuticals Corporation (RXII), Repros Therapeutics (RPRX), OncoGenex Pharmaceuticals (OGXI), Roka Bioscience (ROKA), Jaguar Animal Health (JAGX), Transgenomic (PRPO), Metabolix (YTEN), Ixico Plc (IXI), Akers Biosciences (AKR), Synairgen plc (SNG), Ampliphi Biosciences Corp (APHB), Rosetta Genomics (ROSG), Anacor Pharmaceuticals (ANAC), ANI Pharmaceuticals (BPAX), Celator Pharmaceuticals (CPXX), Cellular Dynamics International (ICEL) and Covance (CVD).
Who are Genedrive PLC's key executives?
Genedrive PLC's management team includes the folowing people:
- David Budd, Chief Executive Officer, Director
- Matthew Fowler, Chief Financial Officer, Director
- H. John J. Rylands, Financial Director, Company Secretary, Executive Director
- Catherine Booth Ph.D., Managing Director - Contract Research Services, Executive Director
- Allan Brown, Chief Operating Officer - Diagnostics division, Executive Director
- Ian David Gilham Ph.D., Non-Executive Chairman of the Board
- Roger Lloyd Ph.D., Non-Executive Director
- Robert Nolan Ph.D., Non-Executive Director
How do I buy Genedrive PLC stock?
Shares of Genedrive PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Genedrive PLC's stock price today?
MarketBeat Community Rating for Genedrive PLC (LON GDR)MarketBeat's community ratings are surveys of what our community members think about Genedrive PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Genedrive PLC stock can currently be purchased for approximately GBX 42.50.
Consensus Ratings for Genedrive PLC (LON:GDR) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||1 Buy Rating|
|Consensus Rating:||Buy (Score: 3.00)|
|Consensus Price Target: ||GBX 200|
Analysts' Ratings History for Genedrive PLC (LON:GDR)
(Data available from 7/28/2015 forward)
|10/11/2016||Peel Hunt||Reiterated Rating||Buy||GBX 200|
Earnings History for Genedrive PLC (LON:GDR)Earnings History by Quarter for Genedrive PLC (LON GDR)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Earnings Estimates for Genedrive PLC (LON:GDR)
Current Year EPS Consensus Estimate: $-34.10 EPS
Dividend History for Genedrive PLC (LON:GDR)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Genedrive PLC (LON:GDR)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Genedrive PLC (LON:GDR)
Latest Headlines for Genedrive PLC (LON:GDR)
No headlines for this company have been tracked by MarketBeat.com
Genedrive PLC (GDR) Chart for Friday, July, 28, 2017